Sign in
4

Changes in Ownership

Acumen Pharmaceuticals, Inc. Filed Acc 0001576885-24-000013

Chief Operating Officer acquired 73,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Barton Russell Chief Operating Officer 2024-01-02 Grant or award +73,000 99,700 D
Derivatives
Barton Russell Chief Operating Officer 2024-01-02 Grant or award · Employee Stock Option (right to buy) +110,000 110,000 D
Loading xslF345X05/wk-form4_1704403365.xml…